Table 4.
Antidiabetes functionality of phlorotannins.
Compounds | Origin | Antidiabetic Activities | Test System | Dosage * | Reference |
---|---|---|---|---|---|
Dieckol | E. cava | Suppress α-glucosidase. | Recombinant Human Aldo-keto Reductase rhAKR1B10 | 10 μM | [57] |
6,6′-Bieckol | E. cava | Suppress PTP 1B. | Same as above | 10 μM | [57] |
7-Phloroeckol | E. cava | Suppress ACE and α-glucosidase. | Same as above | 10 μM | [57] |
2-phloroeckol | E. cava | Suppresss α-glucosidase and PTP 1B. | Same as above and pNPP substrate |
10 μM. 10 and 5 mM |
[54,55,57] |
α-amylase, α-glucosidase, glucose induced protein glycation and glucose diffusion through dialysis membrane | 133.33 µg/mL to 6.66 µg/mL |
||||
Phlorofucofuroeckol-A | E. cava | Suppress α-glucosidase, PTP 1B, ACE, AGEs, and Aldose reductase. | pNPP substrate | 25 and 10 mM | [54,55,56,58] |
AGE assay | 200, 100, 50 mg/mL Positive contol: aminoguanidine |
||||
α-amylase, α-glucosidase, glucose-induced protein glycation and glucose diffusion through dialysis membrane | 133.33 µg/mL to 6.66 µg/mL |
||||
Phloroglucinol, Eckol, Dieckol, and Phlorofucofuroeckol | E. stolonifera | All can suppress α-glucosidase | Recombinant Human Aldo-keto Reductase rhAKR1B10 and type 2 diabetic db/db mice |
10 μM | [53,57] |
* Blank was used as negative control in all the cited research.